Federal Contract Awards

3

awards

Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.

Awardee

is

M3QDM72NME75

	Award ID	Description	Recipient	Total Value	Awarding Agency	Funding Agency	Set Aside	NAICS	PSC	Award Date	Start Date	End Date
	75A50126C00005	THE PURPOSE OF THIS AWARD IS TO ADVANCE THE DEVELOPMENT OF ISOLA'S NEBULIZATION THERAPY, A MEDICAL COUNTERMEASURE DESIGNED TO PREVENT AND TREAT PULMONARY FOAM THE INHALATION OF CHEMICAL AGENTS CAUSES.	ISOLA THERAPEUTICS INC	$7,485,417	OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE	OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE	—	541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)	AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT	Apr 27, 2026	May 1, 2026	Oct 31, 2028
	75A50123C00031	R&D FOR ENDOBRONCHIAL LAVAGE (EBL) TO PREVENT AND TREAT LUNG DAMAGE FROM PULMONARY CHEMICAL AGENTS AOI #15: REDIRECT (REPURPOSING DRUGS IN RESPONSE TO CHEMICAL THREATS)	ISOLA THERAPEUTICS INC	$749,999	OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE	OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE	—	541714Research and Development in Biotechnology (except Nanobiotechnology)	AN14HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES	Jul 11, 2023	Jul 12, 2023	Jul 11, 2025
	75N91022C00018	PHASE I -TOPIC 431 - DRUG DELIVERY BY ENDOESOPHAGEAL LAVAGE (EEL) TO TREAT ESOPHAGEAL CANCER	ISOLA THERAPEUTICS INC	$455,000	NATIONAL INSTITUTES OF HEALTH	NATIONAL INSTITUTES OF HEALTH	—	541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)	AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH	Aug 24, 2022	Sep 15, 2022	Mar 14, 2025

Page 1 of 1